These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
702 related articles for article (PubMed ID: 15472409)
21. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859 [TBL] [Abstract][Full Text] [Related]
22. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644 [TBL] [Abstract][Full Text] [Related]
23. Lack of association between the glutathione-s-transferase genes (GSTT1 and GSTM1) and nasal polyposis. Arbag H; Cora T; Acar H; Ozturk K; Sari F; Ulusoy B Rhinology; 2006 Mar; 44(1):14-8. PubMed ID: 16550944 [TBL] [Abstract][Full Text] [Related]
24. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Mo Z; Gao Y; Cao Y; Gao F; Jian L Prostate; 2009 May; 69(6):662-88. PubMed ID: 19143011 [TBL] [Abstract][Full Text] [Related]
25. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Srivastava DS; Mishra DK; Mandhani A; Mittal B; Kumar A; Mittal RD Eur Urol; 2005 Aug; 48(2):339-44. PubMed ID: 16005379 [TBL] [Abstract][Full Text] [Related]
26. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803 [TBL] [Abstract][Full Text] [Related]
27. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer]. Guan TY; Li M; Na YQ Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816 [TBL] [Abstract][Full Text] [Related]
28. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492 [TBL] [Abstract][Full Text] [Related]
29. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Jourenkova-Mironova N; Voho A; Bouchardy C; Wikman H; Dayer P; Benhamou S; Hirvonen A Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):185-8. PubMed ID: 10067818 [TBL] [Abstract][Full Text] [Related]
30. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Tamer L; Ateş NA; Ateş C; Ercan B; Elipek T; Yildirim H; Camdeviren H; Atik U; Aydin S Cell Biochem Funct; 2005; 23(4):267-72. PubMed ID: 15473001 [TBL] [Abstract][Full Text] [Related]
31. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218 [TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060 [TBL] [Abstract][Full Text] [Related]
33. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. Mittal RD; Manchanda PK; Bid HK; Ghoshal UC J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649 [TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD). Faramawy MM; Mohammed TO; Hossaini AM; Kashem RA; Abu Rahma RM J Crit Care; 2009 Sep; 24(3):e7-10. PubMed ID: 19664521 [TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Dialyna IA; Miyakis S; Georgatou N; Spandidos DA Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704 [TBL] [Abstract][Full Text] [Related]
36. Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Sharma A; Sharma JK; Murthy NS; Mitra AB Neoplasma; 2004; 51(1):12-6. PubMed ID: 15004652 [TBL] [Abstract][Full Text] [Related]
37. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703 [TBL] [Abstract][Full Text] [Related]
38. Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Sobti RC; Kaur S; Kaur P; Singh J; Gupta I; Jain V; Nakahara A Cancer Genet Cytogenet; 2006 Apr; 166(2):117-23. PubMed ID: 16631467 [TBL] [Abstract][Full Text] [Related]
39. Glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) polymorphisms in a sample of the population in Northern Italy. Bigatti MP; Santovito A Genetika; 2007 Jun; 43(6):827-30. PubMed ID: 17853809 [TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer. Oude Ophuis MB; Manni JJ; Peters WH Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]